PL2454266T3 - Sól cytrynianowa 9E-15-(2-pirolidyn-1-ylo-etoksy)-7,12,25-trioksa-19,21,24-triaza-tetracyklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaenu - Google Patents

Sól cytrynianowa 9E-15-(2-pirolidyn-1-ylo-etoksy)-7,12,25-trioksa-19,21,24-triaza-tetracyklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaenu

Info

Publication number
PL2454266T3
PL2454266T3 PL10737645T PL10737645T PL2454266T3 PL 2454266 T3 PL2454266 T3 PL 2454266T3 PL 10737645 T PL10737645 T PL 10737645T PL 10737645 T PL10737645 T PL 10737645T PL 2454266 T3 PL2454266 T3 PL 2454266T3
Authority
PL
Poland
Prior art keywords
nonaene
hexacosa
trioxa
tetracyclo
triaza
Prior art date
Application number
PL10737645T
Other languages
English (en)
Inventor
Brian Dymock
Cheng Hsia Angeline Lee
Anthony Deodaunia William
Original Assignee
Cell Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Therapeutics Inc filed Critical Cell Therapeutics Inc
Publication of PL2454266T3 publication Critical patent/PL2454266T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL10737645T 2009-07-15 2010-07-14 Sól cytrynianowa 9E-15-(2-pirolidyn-1-ylo-etoksy)-7,12,25-trioksa-19,21,24-triaza-tetracyklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaenu PL2454266T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22560909P 2009-07-15 2009-07-15
PCT/SG2010/000265 WO2011008172A1 (en) 2009-07-15 2010-07-14 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt
EP10737645.1A EP2454266B1 (en) 2009-07-15 2010-07-14 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt

Publications (1)

Publication Number Publication Date
PL2454266T3 true PL2454266T3 (pl) 2014-01-31

Family

ID=42790728

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10737645T PL2454266T3 (pl) 2009-07-15 2010-07-14 Sól cytrynianowa 9E-15-(2-pirolidyn-1-ylo-etoksy)-7,12,25-trioksa-19,21,24-triaza-tetracyklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaenu

Country Status (19)

Country Link
US (1) US9062074B2 (pl)
EP (1) EP2454266B1 (pl)
JP (2) JP6013911B2 (pl)
CN (1) CN102762577B (pl)
AR (2) AR077483A1 (pl)
BR (1) BR112012000750B1 (pl)
CA (1) CA2768210C (pl)
DK (1) DK2454266T3 (pl)
ES (1) ES2429525T3 (pl)
HK (1) HK1178159A1 (pl)
HR (1) HRP20130941T1 (pl)
MX (1) MX2012000680A (pl)
PL (1) PL2454266T3 (pl)
PT (1) PT2454266E (pl)
RU (1) RU2543721C2 (pl)
SI (1) SI2454266T1 (pl)
SM (1) SMT201300112B (pl)
TW (1) TWI537276B (pl)
WO (1) WO2011008172A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3247362A4 (en) 2014-11-17 2018-10-10 Context Biopharma Inc. Onapristone extended-release compositions and methods
AU2016326657B2 (en) 2015-09-25 2019-10-24 Context Biopharma, Inc. Methods of making onapristone intermediates
KR20180113988A (ko) 2015-12-15 2018-10-17 컨텍스트 바이오파마 인코포레이티드 비정질 오나프리스톤 조성물 및 그 제조방법
WO2018102369A1 (en) 2016-11-30 2018-06-07 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110603A (en) * 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
WO2004078682A2 (en) 2003-03-05 2004-09-16 Irm Llc Cyclic compounds and compositions as protein kinase inhibitors
JP5380073B2 (ja) * 2005-11-16 2014-01-08 エス*バイオ プライベート リミティッド ヘテロアルキル結合ピリミジン誘導体

Also Published As

Publication number Publication date
US9062074B2 (en) 2015-06-23
HRP20130941T1 (hr) 2013-11-08
SI2454266T1 (sl) 2013-10-30
JP2012533539A (ja) 2012-12-27
CN102762577A (zh) 2012-10-31
JP2015164941A (ja) 2015-09-17
CA2768210A1 (en) 2011-01-20
WO2011008172A1 (en) 2011-01-20
BR112012000750A2 (pt) 2016-08-09
JP6013911B2 (ja) 2016-10-25
ES2429525T3 (es) 2013-11-15
TWI537276B (zh) 2016-06-11
EP2454266A1 (en) 2012-05-23
MX2012000680A (es) 2012-02-28
SMT201300112B (it) 2013-11-08
PT2454266E (pt) 2013-10-10
CA2768210C (en) 2017-08-15
US20120196876A1 (en) 2012-08-02
TW201107336A (en) 2011-03-01
BR112012000750A8 (pt) 2018-02-06
DK2454266T3 (da) 2013-09-08
BR112012000750B1 (pt) 2021-05-25
RU2543721C2 (ru) 2015-03-10
AR077483A1 (es) 2011-08-31
AR114987A2 (es) 2020-11-11
CN102762577B (zh) 2015-01-07
EP2454266B1 (en) 2013-07-10
HK1178159A1 (en) 2013-09-06
RU2012105044A (ru) 2013-08-20

Similar Documents

Publication Publication Date Title
HK1179617A1 (en) 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro- [1,4]oxazepin-5-ylamine compounds 2567--[14]-3- 2367--[14]-5-
IL215908A0 (en) Pyrrolo [2,3.b] pyridines which inhibit raf protein kinase
AP2012006216A0 (en) Benzimidazole-imidazole derivatives.
HRP20150107T1 (en) Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
SI2013208T1 (sl) Piridin(3,4-b)pirazinoni
IL217918A0 (en) 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazine derivatives
IL222977A0 (en) Novel 3,5- disubstituted-3 h-imidazolo[5-b]pyridine and 3,5-disubstituted-3h-[1.2.3]triazolo[4,5]py
ZA201107350B (en) Imidazo [2 1 b] [1, 3, 4] thiadiazole derivatives
ZA201206630B (en) Hetaryl-[1,8]naphthyridine derivatives
PL2531505T3 (pl) Sposób wytwarzania kompleksów 3,7-diaza-bicyklo[3.3.1]nonanu z metalami
HK1198586A1 (zh) -二氟甲基- -二氫- 噁嗪- -胺衍生物
ZA201204135B (en) 3,4,4a,10b-tetrahydro-1h-thiopyrano-[4.3-c]isoquinoline derivatives
IL289379A (en) Citrate salt of 11-(2-pyrrolidin-1-yl-ethoxy)-19,14-dioxa-26,7,5-triaza-tetracyclo[1.1.3.19(6,2)1(12,8)]hepatacosa- 1(25),2(26),12,10,8,5,3(27)j23,21,16–Decan
IL217656A (en) Method for producing 1,1,3-trichloro-1-propane
IL221479A0 (en) Triazolo [4,5-b] pyridin derivatives
EP2152095A4 (en) FOOD THICKENER, METHOD FOR PRODUCING THE FOOD THICKENER
HK1178159A1 (en) 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22- nonaene citrate salt 9e-15-(2--1--)-71225--192124-- [18311(25)1(1418)]-1(24)249141618(26)20 22-
HRP20150413T8 (en) 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene maleate salt
AP2010005479A0 (en) Phospohorous pentoxide producing methods.
GB2476643B (en) 1,4-Dihydro-1,4-dioxonaphtalene derivatives as anticoagulants
IL206666A0 (en) N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-
IL206668A0 (en) N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-
IL219623A0 (en) [1,5]-diazocin derivatives
TH0901005537B (th) 11-(2-ไพร์โรลิดิน-1-อิล-เอทอกซี)-14,19-ไดออกซา-5,7,26-ไตรอะซา-เตตราไซโคล[19.3.1.1(2,6).1(8,12)]เฮปทาโคซา-1(25),2(26),3,5,8,10,12(27),16,21,23-เดคาอีน มาลีเอท ซอลท์
PL2531504T3 (pl) Sposób wytwarzania roztworów kompleksów metali z 3,7-diazabicyklo[3.3.1]nonanem